With a market cap of $31.3 billion, Verisk Analytics, Inc. (VRSK) is a data analytics and technology company that provides risk assessment, decision support solutions, and industry data primarily for the insurance, energy, and financial services sectors. Headquartered in Jersey City, New Jersey, the company helps businesses analyze large datasets to assess risk, improve operational efficiency, and make more informed strategic decisions.
Companies valued at $10 billion or more are generally described as “large-cap stocks,” and VRSK fits that description perfectly, with its market cap exceeding that mark, indicating its size, influence, and dominance in the consulting services industry.
Despite its considerable strength, VRSK is down 37.2% from its 52-week high of $322.92 reached on June 5. Over the past three months, VRSK stock has fallen 5.5%, compared to a 4.1% drop for the Nasdaq Composite ($NASX) over the same period.
Shares of VRSK are down 22.9% in six months and 32% over the past 52 weeks, significantly underperforming the NASX’s six-month gains of 3.7% and 29.9% returns over the past year.
Confirming the bearish trend, VRSK has been trading below its 50-day and 200-day moving averages since early July last year.
On February 23, Verisk Analytics announced that it had entered into $1.5 billion in accelerated share repurchase (ASR) agreements with HSBC Bank USA and Wells Fargo Bank to buy back its common stock. The transaction will begin with an initial delivery of approximately 7 million shares, while the final number of shares purchased will depend on the volume-weighted average price of the stock during the accounting period. The agreements are expected to be completed in the third quarter of fiscal 2026, and after the program approximately $1 billion will remain under Virsk’s existing share repurchase authority. Shares of VRSK rose 5.3% in the next trading session.
In the competitive arena of consulting services, Equifax Inc. (EFX) Leading the way is VRSK with a 20.2% decline over the past six months and a 21.6% loss over the past 52 weeks.
The stock has a consensus “moderate buy” rating from the 20 analysts that cover it, and an average price target of $233.47 suggesting a potential upside of 15.2% from current price levels.
As of the date of publication, Kritika Sarma had no position (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com
